The novel mechanism of YY1, ARAP1-AS2, and ARAP1 in regulating aberrant glycolysis and fibrosis by EGFR/PKM2/HIF-1α pathway will further enhance our understanding of lncRNA functions in DKD and may suggest a potential therapeutic strategy for DKD. This evidence concerns the gene ARAP1 and diabetic kidney disease.